Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Refractory B-cell Non Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05319028
What this trial is testing

Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Non-GCB/ABC Diffuse Large B-Cell LymphomaWith and Without MyD88 and/or CD79B Mutations
Calithera Biosciences, Inc 2
Early research (Phase 1)Study completedNCT02315612
What this trial is testing

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

Who this might be right for
NHLLarge Cell LymphomaFollicular Lymphoma+7 more
National Cancer Institute (NCI) 134
Early research (Phase 1)WithdrawnNCT02780830
What this trial is testing

AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Core: Relapsed or Refractory Diffuse Large B-Cell LymphomaModule 1: Non-GCB Diffuse Large B-Cell Lymphoma
AstraZeneca
Testing effectiveness (Phase 2)Ended earlyNCT04659044
What this trial is testing

Polatuzumab Vedotin, Venetoclax, and Rituximab and Hyaluronidase Human for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma+11 more
Academic and Community Cancer Research United 3
Early research (Phase 1)Study completedNCT00513474
What this trial is testing

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Massachusetts General Hospital 46
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Ended earlyNCT02109224
What this trial is testing

Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaCutaneous B-Cell Non-Hodgkin Lymphoma+26 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Ended earlyNCT00185679
What this trial is testing

Haploid Allogeneic Transplant Using the CliniMACS System

Who this might be right for
Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk FactorsChronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic PhaseMyelodysplastic Syndrome (MDS) - High and Intermediate Risk+2 more
Ginna Laport 13
Testing effectiveness (Phase 2)UnknownNCT01676558
What this trial is testing

A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma
Korea Cancer Center Hospital 24
Early research (Phase 1)Study completedNCT02303392
What this trial is testing

Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Prolymphocytic LeukemiaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Mantle Cell Lymphoma+2 more
Jennifer Woyach 34
Early research (Phase 1)Ended earlyNCT03876028
What this trial is testing

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Who this might be right for
Diffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 10
Not applicableEnded earlyNCT00946283
What this trial is testing

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersLeukemia+7 more
Rutgers, The State University of New Jersey 30
Testing effectiveness (Phase 2)Study completedNCT01326702
What this trial is testing

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult Solid Neoplasm+35 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00052572
What this trial is testing

Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT02568683
What this trial is testing

Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Non-Hodgkin Lymphoma
Gilead Sciences 10
Early research (Phase 1)Active Not RecruitingNCT05627245
What this trial is testing

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell TypeRecurrent Follicular Lymphoma+11 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Active Not RecruitingNCT03150329
What this trial is testing

Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.

Who this might be right for
Grade 3b Follicular LymphomaRecurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HLRecurrent Classic Hodgkin Lymphoma+13 more
City of Hope Medical Center 52
Testing effectiveness (Phase 2)Study completedNCT02271945
What this trial is testing

Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas

Who this might be right for
Relapsed/Refractory Aggressive B-cell Lymphomas
MedImmune LLC 10
Early research (Phase 1)Study completedNCT00994500
What this trial is testing

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germ Cell Tumor+32 more
National Cancer Institute (NCI) 20
Next Page